• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清β2-微球蛋白和外周血嗜酸性粒细胞用于评估奥密克戎变异株新冠病毒感染的严重程度和预后。

Serum beta2-microglobulin and peripheral blood eosinophils for the assessment of severity and prognosis with omicron variant COVID-19 infection.

作者信息

Tan Jie, Fang Hanxi, Hu Xiao, Yue Ming, Yang Junling

机构信息

Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, China.

出版信息

Front Mol Biosci. 2024 Nov 20;11:1476080. doi: 10.3389/fmolb.2024.1476080. eCollection 2024.

DOI:10.3389/fmolb.2024.1476080
PMID:39633986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614729/
Abstract

BACKGROUND

The Omicron variant's high transmissibility has made it the most widespread novel coronavirus variant. Elevated serum β2-MG levels from viral infections and EOS' role in viral clearance have garnered attention. However, their predictive value for Omicron's severity and prognosis needs further exploration.

METHODS

This retrospective study included 424 patients with confirmed COVID-19 Omicron variant admitted to the Second Hospital of Jilin University in Changchun, China, of whom 128 experienced in-hospital mortality. Patients were divided into high and low groups according to β2-MG and EOS levels; the relationship between disease severity and patient prognosis was analyzed.

RESULTS

Our findings showed that severe-to-critical Omicron patients had higher β2-MG levels than mild-normal patients. Conversely, EOS levels were higher in mild-moderate cases. Both β2-MG and EOS levels normalized when Omicron patients tested negative for nucleic acid. Deceased Omicron patients had significantly lower pre-mortem EOS levels. Elevated β2-MG and lower EOS levels correlated with reduced overall survival. Multivariate COX regression analysis indicated that elevated β2-MG was an independent adverse prognostic factor for Omicron patients.

CONCLUSION

High serum β2-MG levels and low eosinophil levels upon admission correlate with omicron variant severity and prognosis. β2-MG is an independent risk factor for poor outcomes in omicron patients.

摘要

背景

奥密克戎变异株的高传播性使其成为传播最广泛的新型冠状病毒变异株。病毒感染导致血清β2-微球蛋白(β2-MG)水平升高以及嗜酸性粒细胞(EOS)在病毒清除中的作用已受到关注。然而,它们对奥密克戎变异株严重程度和预后的预测价值有待进一步探索。

方法

这项回顾性研究纳入了424例确诊感染奥密克戎变异株的新冠肺炎患者,这些患者均入住中国长春吉林大学第二医院,其中128例在住院期间死亡。根据β2-MG和EOS水平将患者分为高、低两组;分析疾病严重程度与患者预后之间的关系。

结果

我们的研究结果表明,奥密克戎变异株感染的重症至危重症患者的β2-MG水平高于轻症至普通型患者。相反,轻症至中型病例的EOS水平较高。当奥密克戎变异株感染患者核酸检测呈阴性时,β2-MG和EOS水平均恢复正常。死亡的奥密克戎变异株感染患者生前EOS水平显著降低。β2-MG升高和EOS水平降低与总生存率降低相关。多因素COX回归分析表明,β2-MG升高是奥密克戎变异株感染患者独立的不良预后因素。

结论

入院时血清β2-MG水平升高和嗜酸性粒细胞水平降低与奥密克戎变异株感染的严重程度和预后相关。β2-MG是奥密克戎变异株感染患者预后不良的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/9d76b5997a2d/fmolb-11-1476080-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/5d199872f6a9/fmolb-11-1476080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/2c77acaf0f43/fmolb-11-1476080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/339ba36cc90f/fmolb-11-1476080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/f344d207165d/fmolb-11-1476080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/591bf18c0433/fmolb-11-1476080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/9d76b5997a2d/fmolb-11-1476080-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/5d199872f6a9/fmolb-11-1476080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/2c77acaf0f43/fmolb-11-1476080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/339ba36cc90f/fmolb-11-1476080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/f344d207165d/fmolb-11-1476080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/591bf18c0433/fmolb-11-1476080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ed/11614729/9d76b5997a2d/fmolb-11-1476080-g006.jpg

相似文献

1
Serum beta2-microglobulin and peripheral blood eosinophils for the assessment of severity and prognosis with omicron variant COVID-19 infection.血清β2-微球蛋白和外周血嗜酸性粒细胞用于评估奥密克戎变异株新冠病毒感染的严重程度和预后。
Front Mol Biosci. 2024 Nov 20;11:1476080. doi: 10.3389/fmolb.2024.1476080. eCollection 2024.
2
Elevated serum beta-2 microglobulin level predicts short-term poor prognosis of patients with acute omicron variant COVID-19 infection.血清β-2 微球蛋白水平升高可预测急性奥密克戎变异株 COVID-19 感染患者短期预后不良。
Front Cell Infect Microbiol. 2023 Jul 13;13:1204326. doi: 10.3389/fcimb.2023.1204326. eCollection 2023.
3
Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.循环嗜酸性粒细胞与 COVID-19 疫苗反应性和 SARS-CoV-2 奥密克戎变异感染患者疾病严重程度相关。
BMC Pulm Med. 2023 May 22;23(1):177. doi: 10.1186/s12890-023-02473-w.
4
COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms.高血嗜酸性粒细胞计数的 COPD 患者感染奥密克戎的比例较低,感染后的症状也较轻。
Clin Respir J. 2024 Jun;18(6):e13790. doi: 10.1111/crj.13790.
5
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
6
Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.非重症奥密克戎变异株 SARS-CoV-2 感染患者的免疫与病毒脱落持续时间的关系。
Front Public Health. 2022 Dec 22;10:1032957. doi: 10.3389/fpubh.2022.1032957. eCollection 2022.
7
[Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].317例急性奥密克戎变异株感染患者自身免疫相关指标的回顾性观察与分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):581-585. doi: 10.3760/cma.j.cn121430-20220418-00383.
8
Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variant.轻度/中度新型冠状病毒奥密克戎变异株感染者心律失常的危险因素及短期预后因素分析
Front Med (Lausanne). 2023 Jul 27;10:1186200. doi: 10.3389/fmed.2023.1186200. eCollection 2023.
9
Omicron variant infection worsen the prognosis of haemodialysis (HD) patients.奥密克戎变异株感染使血液透析(HD)患者的预后恶化。
Ann Med. 2024 Dec;56(1):2394582. doi: 10.1080/07853890.2024.2394582. Epub 2024 Aug 25.
10
Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.17 例感染 SARS-CoV-2 奥密克戎变异株的输入性病例的流行病学特征。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Mar 28;47(3):344-351. doi: 10.11817/j.issn.1672-7347.2022.220040.

引用本文的文献

1
Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19.嗜酸性粒细胞减少预示着感染新冠病毒奥密克戎变异株的肺癌患者预后不良。
Front Med (Lausanne). 2025 Jul 9;12:1583843. doi: 10.3389/fmed.2025.1583843. eCollection 2025.

本文引用的文献

1
Elevated serum beta-2 microglobulin level predicts short-term poor prognosis of patients with acute omicron variant COVID-19 infection.血清β-2 微球蛋白水平升高可预测急性奥密克戎变异株 COVID-19 感染患者短期预后不良。
Front Cell Infect Microbiol. 2023 Jul 13;13:1204326. doi: 10.3389/fcimb.2023.1204326. eCollection 2023.
2
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version).新型冠状病毒肺炎诊疗方案(试行第九版)
Infect Dis Immun. 2022 Jun 29;2(3):135-144. doi: 10.1097/ID9.0000000000000059. eCollection 2022 Jul.
3
Lifting the Veil: Characteristics, Clinical Significance, and Application of β-2-Microglobulin as Biomarkers and Its Detection with Biosensors.
揭开面纱:β-2-微球蛋白作为生物标志物的特征、临床意义及其应用,以及生物传感器的检测。
ACS Biomater Sci Eng. 2022 Aug 8;8(8):3142-3161. doi: 10.1021/acsbiomaterials.2c00036. Epub 2022 Jul 18.
4
CSF neopterin and beta-2-microglobulin as inflammation biomarkers in newborns with hypoxic-ischemic encephalopathy.脑脊液新蝶呤和β2-微球蛋白作为缺氧缺血性脑病新生儿的炎症生物标志物。
Pediatr Res. 2023 Apr;93(5):1328-1335. doi: 10.1038/s41390-022-02011-0. Epub 2022 Apr 6.
5
Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.嗜酸粒细胞计数对 COVID-19 疾病进展和结局的预测价值:对中国武汉雷神山医院的回顾性研究。
J Intensive Care Med. 2022 Mar;37(3):359-365. doi: 10.1177/08850666211037326. Epub 2021 Sep 22.
6
Effectiveness of corticosteroids to treat severe COVID-19: A systematic review and meta-analysis of prospective studies.皮质类固醇治疗重症 COVID-19 的疗效:前瞻性研究的系统评价和荟萃分析。
Int Immunopharmacol. 2021 Nov;100:108121. doi: 10.1016/j.intimp.2021.108121. Epub 2021 Sep 3.
7
Relationship between blood eosinophil levels and COVID-19 mortality.血液嗜酸性粒细胞水平与新型冠状病毒肺炎死亡率之间的关系。
World Allergy Organ J. 2021 Mar;14(3):100521. doi: 10.1016/j.waojou.2021.100521. Epub 2021 Feb 11.
8
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.应用血清β2-微球蛋白水平对伯基特淋巴瘤患者进行预后分层。
Cancer Res Treat. 2021 Jul;53(3):847-856. doi: 10.4143/crt.2020.1060. Epub 2020 Dec 17.
9
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.评价嗜酸性粒细胞减少症作为 COVID-19 感染的诊断和预后指标。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:137-141. doi: 10.1111/ijlh.13425. Epub 2020 Dec 8.
10
Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.人白细胞抗原 I 类和β2-微球蛋白在结直肠癌中的表达及其预后影响。
Cancer Sci. 2021 Jan;112(1):91-100. doi: 10.1111/cas.14723. Epub 2020 Nov 28.